G. Clifford
Epidemiology · International Journal of Cancer · 2003–2020
A researcher in the Science corpus: 12 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 43 citations into it; #1,217 of 2,148 by trust here, #419 by citations
- Obstetrics and Gynecology — 14 citations into it; #57 of 81 by trust here, #10 by citations
Whom G. Clifford trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Clifford overall
Papers from G. Clifford's perspective
Ordered by how strongly the researchers G. Clifford trusts endorse each paper. Same corpus, a different order for every researcher.
- A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity
- A controlled trial of a human papillomavirus type 16 vaccine. (New England Journal of Medicine)
- Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy… (The Lancet Oncology)
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis (British Journal of Cancer)
- Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. (Journal of the National Cancer Institute)
- Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. (Journal of the National Cancer Institute)
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis (British Journal of Cancer)
- Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. (Vaccine)
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. (The Lancet Oncology)
- A review of human carcinogens--Part B: biological agents. (The Lancet Oncology)
Their papers
- Estimates of the global burden of cervical cancer associated with HIV (2020) — 698 citations
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. (2019) — 1,828 citations
- Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer (2012) — 906 citations
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication (2011) — 1,062 citations
- Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysis (2009) — 986 citations
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update (2007) — 1,732 citations
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. (2007) — 1,688 citations
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (2006) — 661 citations
- Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. (2005) — 899 citations
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review (2005) — 2,314 citations
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis (2003) — 1,749 citations
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis (2003) — 722 citations